We are creators of targeted, independent Cannabis journalism. Please email us to discuss advertising in the next issue of Northeast Leaf Magazine. We do not sell stories or coverage. We can offer design services and guidance on promoting your company’s medicinal, recreational, commercial or industrial Cannabis business, product or event within our magazine and on our website, LeafMagazines.com. Email michael@leafmagazines.com to start advertising with NE Leaf!

Thanks for picking up The Psychedelia Issue of the Leaf!

Like Alice in Wonderland falling down the rabbit hole, it feels like society has tripped and awakened into a new age of enlightenment and acceptance for the developing world of psychedelic experiences. This new class of drugs are following the policy road paved by Cannabis – using a combination of science and personal testimonies to advocate for the medicinal and recreational use of natural, plant-based psychedelics and laboratory-derived drugs.

From mushrooms containing psilocybin to ayahuasca in the jungle, the research done via personal experience for decades with shamans and at festivals is shifting to clinical analysis – providing the legal basis for freeing these chemicals and entheogens. It’s all about changing perception, which is ironic given the ego-killing 20,000 foot view of life a good trip provides, and convincing mainstream America that shrooms are more than a hippy escape or the flashback to a bad trip. In a society where we’ve been taught that there’s a pill or doctor for everything, could repackaging mushroom trips into therapy sessions be the missing link?

“WE ARE AT THE BLEEDING EDGE OF EXPLORATION THAT IS FINALLY BEING ALLOWED. ”

Oregon is embarking on this journey with the first state-licensed psilocybin producers, therapy centers and facilitators of psychedelic experiences. I had the pleasure of touring Satya in Medford where the first patients have passed through the veil into a legal trip, complete with pre-trip intake analysis, and a reintegration process to take the experience and apply it into lessons for therapeutic healing back in the “real world.”

Whether we are discussing entheogenic drugs like mushrooms, ayahuasca or toad DMT, or looking at laboratory-developed drugs like MDMA, LSD and Ketamine, we are at the bleeding edge of exploration that is finally being allowed. Research that began in the ‘60s and ‘70s and continued under strict hospital conditions at Johns Hopkins, is now happening all over the world. While recreating Cannabis as medicine in the lab was a failure (search Marinol for more), we can learn a lot by isolating and synthesizing the chemicals that make us trip. In the search for acceptance, we must also search to provide experiences that are familiar in normal life – so that our parents, teachers, police officers and veterans can head to a therapy center, take a capsule or ingest a tea, and have the opportunity to experience the world through the lens of a psychedelic experience.